Predicting left ventricular remodeling after a first myocardial infarction by plasma proteome analysis

Area of Science:

• Cardiology
• Proteomics
• Biomarker Discovery

Background:

• Left ventricular remodeling (LVR) is a common complication after acute myocardial infarction (AMI), occurring in 30% of cases despite therapeutic advances.
• Identifying reliable biomarkers for LVR is crucial for predicting heart failure risk post-AMI.

Purpose of the Study:

• To systematically identify circulating protein biomarkers associated with LVR after anterior wall Q-wave AMI using comparative proteomics.
• To evaluate the potential of these biomarkers in predicting LVR development and progression.

Main Methods:

• A prospective study of 93 patients with anterior wall Q-wave AMI, with echocardiographic follow-up at hospitalization, 3 months, and 1 year.
• Plasma samples collected on day 5 were analyzed using Surface-Enhanced Laser Desorption/Ionization-Time Of Flight (SELDI-TOF) protein chip technology.
• Patients were categorized into no, low, or high LVR groups based on echocardiographic data.

Main Results:

• Comparative proteomics identified post-translational variants of the alpha1-chain of haptoglobin (Hpalpha1) at m/z 9493, 9565, and 9623 as being significantly elevated in patients with LVR.
• The peak at 9493 m/z demonstrated a Receiver Operating Characteristic (ROC) value of 0.71 in distinguishing between remodeling and non-remodeling patients.
• These findings suggest a correlation between specific Hpalpha1 variants and the presence and severity of LVR.

Conclusions:

• The SELDI-TOF proteomic approach successfully identified candidate circulating proteins, specifically Hpalpha1 variants, associated with LVR after AMI.
• These identified Hpalpha1 variants hold promise as potential biomarkers for identifying patients at high risk of developing LVR and subsequent heart failure.
• Further validation studies are required to confirm the clinical utility of these biomarkers in predicting heart failure post-AMI.